Repurposing Pharmaceuticals as Neuroprotective Agents for Cerebral Malaria.

CONCLUSION: The findings of this review highlight recently licensed pharmaceuticals that may developed as future adjunctive therapies for CM.
PMID: 28676008 [PubMed - as supplied by publisher]

Source: Current Clinical Pharmacology - July 4, 2017 Category: Drugs & Pharmacology Authors: Brooks HM, Hawkes MT Tags: Curr Clin Pharmacol Source Type: research